A Pilot study on correlation between Zinc and Magnesium serum concentrations and coronary slow flow phenomenon

Main Article Content

Mostafa Dastani
Mitra Mokhtari
Ramin Khameneh Bagheri
Pirooz Hassanzadeh
Mahdi Jannati Yazdan Abad
Amir Hooshang Mohammadpour
Sepideh Elyasi


Magnesium, Zinc, Slow flow, coronary artery disease, trace elements


Background: The pathophysiology of slow flow includes microvascular disorders, endothelial dysfunction, subclinical atherosclerosis, inflammation and anatomical factors. The role of magnesium and zinc in the development of microvascular and endothelial dysfunctions as well as atherosclerosis has been proven in previous studies, and the mechanism of the development has been studied. The aim of current study was to evaluate the serum concentration of zinc and magnesium in patients with epicardial coronary artery slow flow.

Design: 125 patients who referred to Ghaem Hospital in Mashhad were selected based on inclusion and exclusion criteria. Magnesium and Zinc levels were evaluated in patients. The plasma levels of studied elements were compared among the different groups and the rate of coronary artery slow flow was evaluated based on the TIMI score.

Results: The results of present study indicated that the serum level of Magnesium in the studied groups did not show a significant correlation with rate of coronary artery slow flow (P> 0.05). Serum Zinc concentration was significantly different in the studied groups, which means serum Zinc level in patients without coronary artery occlusion and  without epicardial slow flow were significantly higher than other groups (P> 0.01).

Conclusion: In the present study, no significant relationship was found between the serum level of zinc and magnesium with the intensity of coronary artery slow flow based on TIMI, and further studies seem to be needed to investigate this relationship.


Download data is not yet available.
Abstract 48 | PDF Downloads 21


1. Wang X, Nie SP. The coronary slow flow phenomenon: characteristics, mechanisms and implications. Cardiovascular diagnosis and therapy. 2011 Dec;1(1):37-43. PubMed PMID: 24282683. Pubmed Central PMCID: Pmc3839135. Epub 2011/12/01. eng.
2. Bope E, Kellerman R. The Cardiovascular System. In: Bope E, Kellerman R, editors. Conn's Current Therapy. Philadelphia: Elsevier; 2017. p. 779-158.
3. Kaski JC. Pathophysiology and management of patients with chest pain and normal coronary arteriograms (cardiac syndrome X). Circulation. 2004 Feb 10;109(5):568-72. PubMed PMID: 14769677. Epub 2004/02/11. eng.
4. Porro B, Eligini S, Veglia F, Lualdi A, Squellerio I, Fiorelli S. Nitric oxide synthetic pathway in patients with microvascular angina and its relations with oxidative stress. Oxid Med Cell Longev. 2014;2014:726539. PubMed PMID: 24864190.
5. X Wang, SP Nie, The coronary slow flow phenomenon: characteristics, mechanisms and implications, Cardiovascular diagnosis and therapy. 1 (2011) 37-43.
6. Saris NE, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A. Magnesium. An update on physiological, clinical and analytical aspects. Clinica chimica acta; international journal of clinical chemistry. 2000 Apr;294(1-2):1-26. PubMed PMID: 10727669. Epub 2000/03/23. eng.
7. Shechter M, Sharir M, Labrador MJ, Forrester J, Silver B, Bairey Merz CN. Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation. 2000 Nov 07;102(19):2353-8. PubMed PMID: 11067788. Epub 2000/11/09. eng.
8. Cortese-Krott MM, Kulakov L, Oplander C, Kolb-Bachofen V, Kroncke KD, Suschek CV. Zinc regulates iNOS-derived nitric oxide formation in endothelial cells. Redox biology. 2014;2:945-54. PubMed PMID: 25180171. Pubmed Central PMCID: Pmc4143817. Epub 2014/09/03. eng.
9. Wolf FI, Trapani V, Simonacci M, Ferre S, Maier JA. Magnesium deficiency and endothelial dysfunction: is oxidative stress involved? Magnesium research. 2008 Mar;21(1):58-64. PubMed PMID: 18557135. Epub 2008/06/18. eng.
10. Maier JA, Bernardini D, Rayssiguier Y, Mazur A. High concentrations of magnesium modulate vascular endothelial cell behaviour in vitro. Biochimica et biophysica acta. 2004 May 24;1689(1):6-12. PubMed PMID: 15158908. Epub 2004/05/26. eng.
11. Maier JA, Malpuech-Brugere C, Zimowska W, Rayssiguier Y, Mazur A. Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis. Biochimica et biophysica acta. 2004 May 24;1689(1):13-21. PubMed PMID: 15158909. Epub 2004/05/26. eng.
12. Kolte D, Vijayaraghavan K, Khera S, Sica DA, Frishman WH. Role of magnesium in cardiovascular diseases. Cardiology in review. 2014 Jul-Aug;22(4):182-92. PubMed PMID: 24896250. Epub 2014/06/05. eng.
13. Wang X, Nie SP. The coronary slow flow phenomenon: characteristics, mechanisms and implications. Cardiovascular diagnosis and therapy. 2011 Dec;1(1):37-43. PubMed PMID: 24282683. Pubmed Central PMCID: Pmc3839135. Epub 2011/12/01. eng.
14. Liao F, Folsom AR, Brancati FL. Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. American heart journal. 1998 Sep;136(3):480-90. PubMed PMID: 9736141. Epub 1998/09/15. eng
15. Del Gobbo LC, Imamura F, Wu JH, de Oliveira Otto MC, Chiuve SE, Mozaffarian D. Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies. The American journal of clinical nutrition. 2013 Jul;98(1):160-73. PubMed PMID: 23719551. Pubmed Central PMCID: Pmc3683817. Epub 2013/05/31. eng.
16. Kazemi-Bajestani SM, Ghayour-Mobarhan M, Ebrahimi M, Moohebati M, Esmaeili HA, Parizadeh MR, et al. Serum copper and zinc concentrations are lower in Iranian patients with angiographically defined coronary artery disease than in subjects with a normal angiogram. Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS). 2007;21(1):22-8. PubMed PMID: 17317522. Epub 2007/02/24. eng.

Most read articles by the same author(s)